Pharmacokinetic-pharmacodynamic Interaction Between BIA 3-202 and Levodopa/Carbidopa
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Parkinson's Disease
Related studies linked through entity extraction aliases.
Study to Investigate the Tolerability, Steady-state Pharmacokinetics and Erythrocyte COMT Inhibition of BIA 3-202
- Status
- COMPLETED
- Phase
- PHASE1
Absorption, Distribution, Metabolism and Excretion of [14C]-Labelled BIA 3-202 and Metabolites
- Status
- COMPLETED
- Phase
- PHASE1
Predictors of Motor Progression in Parkinson's Disease
- Status
- COMPLETED
- Phase
- N/A
Monitoring Brain Waves in Response to Visual and/or Auditory Stimulation in Parkinson's Disease Patients
- Status
- UNKNOWN
- Phase
- NA
Effect of Melatonin on Sleep Disturbances in Patients With Parkinson's Disease
- Status
- UNKNOWN
- Phase
- PHASE4
SudoScan as a Biomarker of Parkinson's Disease
- Status
- COMPLETED
- Phase
- NA
A Study in Healthy Male Volunteers to Investigate a New Drug for the Treatment of Parkinson's Disease
- Status
- COMPLETED
- Phase
- PHASE1
Efficacy and Safety Proof of Concept Study in Patients With Parkinson's Disease and End-of-dose Wearing-off (COMPOC)
- Status
- COMPLETED
- Phase
- PHASE2
Pharmacokinetic-Pharmacodynamic Interaction Between Four Different Single Doses of BIA 3-202 and a Single Dose of Levodopa/Benserazide (100/25 mg)
- Status
- COMPLETED
- Phase
- PHASE1
Pharmacokinetic-Pharmacodynamic Interaction Between Four Different Single Doses of BIA 3-202 and a Single Dose of Levodopa/Carbidopa (100/25 mg)
- Status
- COMPLETED
- Phase
- PHASE1
Study to Investigate the Safety, Tolerability, Steady State Pharmacokinetic and Pharmacodynamic Profile of BIA 3-202
- Status
- COMPLETED
- Phase
- PHASE1
Safety, Tolerability, Pharmacokinetics (Including Food Interaction), and Pharmacodynamics of BIA 3-202
- Status
- COMPLETED
- Phase
- PHASE1
Biomarkers in Neural Disorders
- Status
- COMPLETED
- Phase
- N/A
Parkinson's Families Project
- Status
- RECRUITING
- Phase
- N/A
Study Assessing Tolerability and Safety and Exploring the Immunogenicity and Therapeutic Activity of AFFITOPE® PD01A in PD-GBA Patients
- Status
- WITHDRAWN
- Phase
- PHASE1
Dysarthria in Parkinson's Disease: Lusophony vs. Francophony Comparison
- Status
- UNKNOWN
- Phase
- NA
Laughter Therapy Effects on Mood, Stress and Self-efficacy in People With Neurological Diseases.
- Status
- COMPLETED
- Phase
- NA
Defining a PD-specific Breath Fingerprint of Underlying Inflammatory and Neurodegenerative Processes
- Status
- COMPLETED
- Phase
- N/A
Continuous Behavior Assessment of the Effects of a Physical Therapy Program for Patients With Parkinson's Disease
- Status
- UNKNOWN
- Phase
- NA